Drug maker Novartis AG (NOVN.CH) is in advanced talks to acquire MorphoSys AG (MOR.DE), two people familiar with the matter told Reuters on Monday.
The sources added that there is no certainty that negotiations on the deal will be successful and asked to remain anonymous as the matter is confidential. They declined to provide any information on the acquisition price.
MorphoSys shares are currently gaining nearly 37%.

Source: xStation
Daily summary: Semiconductors divert attention from Iran
Will OpenAI help companies implement AI?
Target Hospitality: Is AI pivot paying off?
US OPEN: Semiconductors keep the market at record highs